Opaleye Management Inc. Q2 2016 Filing
Filed August 12, 2016
Portfolio Value
$149.7M
Holdings
49
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —AXOGEN INC | 2,120,000 | $14.6M | 9.74% | |
| 2 | —MEDGENICS INC | 1,950,000 | $10.8M | 7.23% | |
| 3 | AMRNARIAD PHARMACEUTICALS INC | 1,250,000 | $9.2M | 6.17% | |
| 4 | —FIBROGEN INC | 330,000 | $5.4M | 3.62% | |
| 5 | —PROTALIX BIOTHERAPEUTICS INC | 8,200,000 | $5.2M | 3.51% | |
| 6 | —BLUEPRINT MEDICINES | 250,000 | $5.1M | 3.38% | |
| 7 | —INOTEK PHARMACEUTICALS CORP | 645,000 | $4.8M | 3.21% | |
| 8 | —IMPRIMIS PHARMACEUTICALS INC | 1,267,500 | $4.8M | 3.18% | |
| 9 | CMRXEURCODEXIS INC | 1,178,500 | $4.7M | 3.17% | |
| 10 | —ADAMAS PHARMACEUTICALS INC | 300,000 | $4.5M | 3.03% | |
| 11 | —FOAMIX PHARMACEUTICALS LTD | 695,000 | $4.4M | 2.95% | |
| 12 | 2L9CARA THERAPEUTICS | 835,000 | $4.0M | 2.68% | |
| 13 | AGIOAMARIN CORP PLC | 1,760,000 | $3.8M | 2.54% | |
| 14 | ADAPYAGIOS PHARMACEUTICALS | 85,000 | $3.6M | 2.38% | |
| 15 | —HORIZON PHARMA PLC | 200,000 | $3.3M | 2.20% | |
| 16 | RAREULTRAGENYX PHARMACEUTICALS | 65,000 | $3.2M | 2.12% | |
| 17 | —MACROGENICS INC | 112,000 | $3.0M | 2.02% | |
| 18 | GONIMMUNOMEDICS INC | 1,300,000 | $3.0M | 2.01% | |
| 19 | —INTEC PHARMA LTD | 650,000 | $3.0M | 2.00% | |
| 20 | —AMAG PHARMACEUTICALS INC | 120,000 | $2.9M | 1.92% | |
| 21 | CARAEURCHIMERIX INC | 675,000 | $2.7M | 1.77% | |
| 22 | SG7SUPERNUS PHARMACEUTICALS INC | 125,000 | $2.5M | 1.70% | |
| 23 | FGENEURGLOBAL BLOOD THERAPEUTICS IN | 152,000 | $2.5M | 1.68% | |
| 24 | XENEXENON PHARMACEUTICALS INC | 410,000 | $2.4M | 1.62% | |
| 25 | —EDGE THERAPEUTICS INC | 225,600 | $2.3M | 1.52% | |
| 26 | —LION BIOTECHNOLOGIES INC | 260,000 | $2.1M | 1.41% | |
| 27 | —CYNAPSUS THERAPEUTICS INC | 125,000 | $2.1M | 1.40% | |
| 28 | —PARATEK PHARMACEUTICALS INC | 146,700 | $2.0M | 1.36% | |
| 29 | NKTREURNABRIVA THERAPEUTICS AG | 270,000 | $2.0M | 1.35% | |
| 30 | AMAGAQUINOX PHARMACEUTICALS INC | 295,000 | $2.0M | 1.30% | |
| 31 | —EAGLE PHARMACEUTICALS INC | 50,000 | $1.9M | 1.30% | |
| 32 | —ZOGENIX INC | 240,000 | $1.9M | 1.29% | |
| 33 | TREURTRILLIUM THERAPEUTICS INC | 195,000 | $1.8M | 1.17% | |
| 34 | —SERES THERAPEUTICS INC | 57,500 | $1.7M | 1.12% | |
| 35 | —CYTOMX THERAPEUTICS INC | 160,000 | $1.6M | 1.09% | |
| 36 | TGTXTONIX PHARMACEUTICALS HLDG | 800,000 | $1.6M | 1.06% | |
| 37 | —AFFIMED NV | 595,000 | $1.5M | 0.99% | |
| 38 | —INNOCOLL HOLDINGS PLC | 265,000 | $1.5M | 0.98% | |
| 39 | —AURIS MEDICAL HOLDINGS AG | 340,000 | $1.4M | 0.95% | |
| 40 | —OCULAR THERAPEUTIX INC | 260,000 | $1.3M | 0.86% | |
| 41 | —PROTEOSTASIS THERAPEUTICS INC | 105,000 | $1.3M | 0.85% | |
| 42 | CDXSCORIUM INTERNATIONAL INC | 360,000 | $1.2M | 0.83% | |
| 43 | SUPNTENAX THERAPEUTICS INC | 465,000 | $1.2M | 0.79% | |
| 44 | —TG THERAPEUTICS INC | 175,000 | $1.1M | 0.71% | |
| 45 | EGRXEVOKE PHARMA | 130,000 | $891K | 0.60% | |
| 46 | —NEURODERM LTD | 52,500 | $853K | 0.57% | |
| 47 | —CIDARA | 43,000 | $443K | 0.30% | |
| 48 | ACRSADAPTIMMUNE THERAPEUTICS PLC | 40,000 | $326K | 0.22% | |
| 49 | AXGNBIOLINERX LTD | 250,000 | $223K | 0.15% |